3
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Other hematologic neoplasm
46
Lymphoid
30
Myeloid
12
Plasma cell
4
Sarcoma
3
Gastrointestinal
3
Dermatologic
3
Breast
3
Head & Neck
2
Gynecologic
2
Genitourinary
2
CNS
2
Thoracic
1
Other solid neoplasm
1
Other
1
NET
1
Endocrine
1
Classical hematology
1
Conditions
Neuroendocrine Tumors
28
Pheochromocytoma
11
Adrenocortical Carcinoma
11
Carcinoma, Neuroendocrine
10
Thyroid Neoplasms
9
Thyroid Cancer, Papillary
9
Pituitary Neoplasms
9
Sarcoma
7
Small Cell Lung Carcinoma
6
Paraganglioma
6
Neoplasms
6
Adrenal Gland Neoplasms
6
Parathyroid Neoplasms
5
Ovarian Neoplasms
5
Melanoma
5
Cholangiocarcinoma
5
Carcinoid Tumor
5
Pancreatic Neoplasms
4
Neuroblastoma
4
Multiple Endocrine Neoplasia Type 1
4
Insulinoma
4
Central Nervous System Neoplasms
4
Carcinoma, Renal Cell
4
Carcinoma, Non-Small-Cell Lung
4
Carcinoma, Hepatocellular
4
Stomach Neoplasms
3
Osteosarcoma
3
Neoplasm Metastasis
3
Meningioma
3
Lung Neoplasms
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Leukemia
×
Endocrine
×
30 days
×
Clear all
NCT02012699
2026-05-05
iCaRe2
University of Nebraska
Recruiting
999,999 enrolled